Vir Biotechnology, Inc. — Investor Relations & Filings
Vir Biotechnology, Inc. is a clinical-stage immunology company that leverages the immune system to treat and prevent serious infectious diseases and other conditions. The company's pipeline is built on two primary technology platforms: a next-generation antibody platform for identifying and optimizing therapeutic candidates, and the PRO-XTEN® protease-releasable masking technology for applications in oncology. Vir's main therapeutic area is infectious diseases, featuring a leading program for chronic hepatitis delta, and is complemented by strategic programs in oncology. The company has demonstrated its capabilities by developing antibody-based medicines for significant health challenges, including COVID-19 and Ebola.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-28 | English | |
| DEF 14A - Vir Biotechnology, Inc. (0001706431) (Filer) | 2026-04-16 | English | |
| 8-K - Vir Biotechnology, Inc. (0001706431) (Filer) | 2026-04-10 | English | |
| SCHEDULE 13G/A - Vir Biotechnology, Inc. (0001706431) (Subject) | 2026-03-27 | English | |
| 4 - Vir Biotechnology, Inc. (0001706431) (Issuer) | 2026-03-23 | English | |
| 144 - Vir Biotechnology, Inc. (0001706431) (Subject) | 2026-03-23 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
|
ASEP Medical Holdings Inc.
Developing diagnostic and therapeutic solutions to combat a…
|
ASEP | CA | Manufacturing |
|
ASKA Pharmaceutical Holdings CO., Ltd.
Specializes in hormone-related pharmaceuticals for internal…
|
4886 | JP | Manufacturing |
|
ASPEN PHARMACARE HOLDINGS LIMITED
Global specialty and branded pharmaceutical company deliver…
|
APN | ZA | Manufacturing |
|
Aspire Biopharma Holdings, Inc.
Develops sublingual drug delivery technologies for needle-f…
|
ASBP | US | Manufacturing |
|
ASSEMBLY BIOSCIENCES, INC.
A clinical-stage biotech developing small molecule antivira…
|
ASMB | US | Manufacturing |
|
ASSERCA S.R.L.
Specializes in importing, exporting, and manufacturing medi…
|
— | AR | Manufacturing |
Vir Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32538/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32538 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32538 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32538 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32538}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vir Biotechnology, Inc. (id: 32538)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.